Kelly Blanchard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kelly Blanchard has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Beverly Winikoff
SA), Senior Specialist Ibis Reproductive Health, Cambridge, MA, USA
4 shared publicationsTsungai Chipato
University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
3 shared publications- Amanda Dennis
Ibis Reproductive Health, 17 Dunster Street, Suite 201, Cambridge, MA 02138, USA
2 shared publications - Ariane van der Straten
University of California, San Francisco
2 shared publications - Carmela Zuniga
Ibis Reproductive Health, Cambridge, Massachusetts, USA
2 shared publications - Daniel Grossman
Advancing New Standards in Reproductive Health (ANSIRH), Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 1330 Broadway, Oakland, CA, 94612, United States, 1 502-938-1448
2 shared publications
Latest Publications
- Open Access
- 18 February 2025
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 115 (1) , e1987
The incidence of incomplete abortion and the prevalence of abortion-related morbidity in South African public hospitals, 2018
Background. The occurrence of abortion-related morbidity indicates limited access to safe abortion. Globally, unsafe abortions remain a persistent, yet preventable, cause of maternal mortality. South Africa (SA) is internationally recognised for its progressive reproductive rights framework, supported by its Constitution and laws. However, evidence suggests that women encounter barriers to accessing safe abortions, including stigma, resistance from healthcare providers, a shortage of trained professionals and a lack of awareness of their rights. We hypothesised that, 20 years after the promulgation of the Choice on Termination of Pregnancy Act, the incidence of incomplete abortion (ICA) and the prevalence of abortion-related morbidity would change, influenced by access to safe abortion and the introduction of medication abortion. We wanted to compare our data with 2000 and 1994 survey results to assess change. Objectives. To estimate the incidence of incomplete abortion and describe the prevalence of abortion-related morbidity in SA public hospitals in 2018. Methods. This was a cross-sectional, retrospective study. We selected a stratified random sample of public hospitals. We extracted data from medical records of women who presented with ICA during a predetermined 21-day period in 2018. Data were captured directly into a REDCap database. To estimate the national incidence of ICA, we used population estimates for 2018, comprising 17 199 227 women aged 12 - 49 years, and 1 200 436 live births. The prevalence of ICA morbidity is reported. We compared the rates in this study with those reported from similar studies in 2000 and 1994. Results. We found 913 medical records of women presenting with ICA in the 56 public hospitals. ICA incidence was 367 (274 - 459) per 100 000 women aged 12 - 49 years. The average age of the women was 27 years, and the majority had a previous pregnancy before the ICA. A large proportion (73.9%) of women were in the first trimester. There was no sign of infection in 92.5% of records, no organ failure in 99.1% of records and there were no deaths. There was no change in the ICA incidence when compared with the 1994 and 2000 results. Women’s mean age and having a previous pregnancy were similar in the three studies (1994, 2000 and 2018). The proportion of women presenting in the first trimester increased over time: 60.5% in 1994, 67.1% in 2000 and 73.9% in 2018. There has been a decline in the prevalence of abortion-related morbidity, demonstrated by lower levels of severity, no signs of infections and no organ failure. Conclusion. ICA incidence has not changed, but related morbidity is declining. Various factors could explain our findings, but the lack of change in ICA incidence indicates that access to formal abortion care has not improved over the past 20 years.
- 18 February 2025
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 115 (1) , e1987
Open AccessThe incidence of incomplete abortion and the prevalence of abortion-related morbidity in South African public hospitals, 2018
Background. The occurrence of abortion-related morbidity indicates limited access to safe abortion. Globally, unsafe abortions remain a persistent, yet preventable, cause of maternal mortality. South Africa (SA) is internationally recognised for its progressive reproductive rights framework, supported by its Constitution and laws. However, evidence suggests that women encounter barriers to accessing safe abortions, including stigma, resistance from healthcare providers, a shortage of trained professionals and a lack of awareness of their rights. We hypothesised that, 20 years after the promulgation of the Choice on Termination of Pregnancy Act, the incidence of incomplete abortion (ICA) and the prevalence of abortion-related morbidity would change, influenced by access to safe abortion and the introduction of medication abortion. We wanted to compare our data with 2000 and 1994 survey results to assess change. Objectives. To estimate the incidence of incomplete abortion and describe the prevalence of abortion-related morbidity in SA public hospitals in 2018. Methods. This was a cross-sectional, retrospective study. We selected a stratified random sample of public hospitals. We extracted data from medical records of women who presented with ICA during a predetermined 21-day period in 2018. Data were captured directly into a REDCap database. To estimate the national incidence of ICA, we used population estimates for 2018, comprising 17 199 227 women aged 12 - 49 years, and 1 200 436 live births. The prevalence of ICA morbidity is reported. We compared the rates in this study with those reported from similar studies in 2000 and 1994. Results. We found 913 medical records of women presenting with ICA in the 56 public hospitals. ICA incidence was 367 (274 - 459) per 100 000 women aged 12 - 49 years. The average age of the women was 27 years, and the majority had a previous pregnancy before the ICA. A large proportion (73.9%) of women were in the first trimester. There was no sign of infection in 92.5% of records, no organ failure in 99.1% of records and there were no deaths. There was no change in the ICA incidence when compared with the 1994 and 2000 results. Women’s mean age and having a previous pregnancy were similar in the three studies (1994, 2000 and 2018). The proportion of women presenting in the first trimester increased over time: 60.5% in 1994, 67.1% in 2000 and 73.9% in 2018. There has been a decline in the prevalence of abortion-related morbidity, demonstrated by lower levels of severity, no signs of infections and no organ failure. Conclusion. ICA incidence has not changed, but related morbidity is declining. Various factors could explain our findings, but the lack of change in ICA incidence indicates that access to formal abortion care has not improved over the past 20 years.
- 21 October 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 49 (1) , 27-34
Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey
Background Efforts are underway to make a progestin-only pill (POP) over the counter (OTC) in the United States (US); however, little is known about POP user experiences, which could impact uptake and continuation. Methods From January 2020–September 2021, we conducted a cross-sectional online survey with individuals who used OTC POPs in a US trial. We calculated descriptive statistics and Pearson chi-square and Fisher’s exact tests to assess menstrual bleeding acceptability, how OTC POP experiences compared with prior contraceptive methods, and preferred ways to get answers to questions during OTC POP use. Results Among 550 adult and 115 adolescent participants, 80% (n=531) felt their menstrual bleeding was acceptable. Participants reported a range of menstrual bleeding experiences compared with prior long-acting or hormonal methods used; 58% (n=84) said the POP bleeding was similar or better and 36% (n=53) said it was worse. Among participants who used contraception in the month prior to the trial, 77% (n=201) said their overall OTC POP experience was similar or better. Top benefits compared with prior methods included less worry about pregnancy, ease of access, fewer side effects, and greater decision-making power. Adults preferred to get answers about OTC POPs via webpage or app, whereas teens preferred asking pharmacists or other healthcare providers. Conclusions Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.
- 21 October 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 49 (1) , 27-34
Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey
Background Efforts are underway to make a progestin-only pill (POP) over the counter (OTC) in the United States (US); however, little is known about POP user experiences, which could impact uptake and continuation. Methods From January 2020–September 2021, we conducted a cross-sectional online survey with individuals who used OTC POPs in a US trial. We calculated descriptive statistics and Pearson chi-square and Fisher’s exact tests to assess menstrual bleeding acceptability, how OTC POP experiences compared with prior contraceptive methods, and preferred ways to get answers to questions during OTC POP use. Results Among 550 adult and 115 adolescent participants, 80% (n=531) felt their menstrual bleeding was acceptable. Participants reported a range of menstrual bleeding experiences compared with prior long-acting or hormonal methods used; 58% (n=84) said the POP bleeding was similar or better and 36% (n=53) said it was worse. Among participants who used contraception in the month prior to the trial, 77% (n=201) said their overall OTC POP experience was similar or better. Top benefits compared with prior methods included less worry about pregnancy, ease of access, fewer side effects, and greater decision-making power. Adults preferred to get answers about OTC POPs via webpage or app, whereas teens preferred asking pharmacists or other healthcare providers. Conclusions Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.
- Open Access
- 1 May 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 226 (5) , 710.e1-710.e21
Accuracy of self-assessment of gestational duration among people seeking abortion
- 1 May 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 226 (5) , 710.e1-710.e21
Open AccessAccuracy of self-assessment of gestational duration among people seeking abortion
- 1 November 2020
- Published by Elsevier in Women's Health Issues
- Vol. 30 (6) , 416-425
Abortion as a Catastrophic Health Expenditure in the United States
- 1 November 2020
- Published by Elsevier in Women's Health Issues
- Vol. 30 (6) , 416-425
Abortion as a Catastrophic Health Expenditure in the United States
- 1 September 2020
- Published by Elsevier in Contraception
- Vol. 102 (3) , 195-200
Contextualizing Medicaid reimbursement rates for abortion procedures
- 1 September 2020
- Published by Elsevier in Contraception
- Vol. 102 (3) , 195-200
Contextualizing Medicaid reimbursement rates for abortion procedures
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 28 (1) , 1774185
Access to later abortion in the United States during COVID-19: challenges and recommendations from providers, advocates, and researchers
Access to later abortion in the United States during COVID-19: Challenges and recommendations from providers, advocates, and researchers. Sexual and Reproductive Health Matters. Accepted .
- 1 January 2020
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 28 (1) , 1774185
Open AccessAccess to later abortion in the United States during COVID-19: challenges and recommendations from providers, advocates, and researchers
Access to later abortion in the United States during COVID-19: Challenges and recommendations from providers, advocates, and researchers. Sexual and Reproductive Health Matters. Accepted .
- Open Access
- 10 October 2018
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 44 (4) , 235-236
Contraception after medication abortion should be determined by convenience and choice
- 10 October 2018
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 44 (4) , 235-236
Open AccessContraception after medication abortion should be determined by convenience and choice
- Open Access
- 17 August 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0201663
Contraceptive use and unintended pregnancy among young women and men in Accra, Ghana
The objective of this study was to determine factors associated with modern contraceptive use and unintended pregnancy among young women and men in Accra, Ghana. From September-December 2013, we conducted a cross-sectional survey with 250 women and 100 men aged 18–24. We explored determinants of modern contraceptive use among males and females and unintended pregnancy among females. Descriptive statistics, chi-square tests, Fisher’s exact tests, and multivariable logistic regression were used. Participants had an average of three lifetime sexual partners, and 91% had one current partner. Overall, 44% reported current modern contraceptive use. In multivariate modeling, modern contraceptive use was associated with higher education compared to primary (AORs 2.1–4.3); ever talking with someone about contraception (AOR 4.7); feeling unsupported by a healthcare provider for contraception (AOR 2.2); and not feeling at risk of unintended pregnancy (AOR 2.7). While ≥70% of participants recognized most contraceptive methods, awareness of some methods was lacking. Nearly all respondents (91%) felt at least one modern method was unsafe. Nearly half of all females (45%) reported their last pregnancy was unintended, and 63% of females and 58% of males felt at risk for future unintended pregnancy. Women were more likely to experience unintended pregnancy if they had ever given birth (AOR 6.7), their sexual debut was 8–14 years versus 20–24 years (AOR 3.4), or they had 3–4 lifetime sexual partners versus 1–2 (AOR 2.4). Targeted interventions are needed to improve understanding of the safety of modern contraceptive methods, increase awareness of long-acting methods, and consequently increase modern contraceptive access and use.
- 17 August 2018
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (8) , e0201663
Open AccessContraceptive use and unintended pregnancy among young women and men in Accra, Ghana
The objective of this study was to determine factors associated with modern contraceptive use and unintended pregnancy among young women and men in Accra, Ghana. From September-December 2013, we conducted a cross-sectional survey with 250 women and 100 men aged 18–24. We explored determinants of modern contraceptive use among males and females and unintended pregnancy among females. Descriptive statistics, chi-square tests, Fisher’s exact tests, and multivariable logistic regression were used. Participants had an average of three lifetime sexual partners, and 91% had one current partner. Overall, 44% reported current modern contraceptive use. In multivariate modeling, modern contraceptive use was associated with higher education compared to primary (AORs 2.1–4.3); ever talking with someone about contraception (AOR 4.7); feeling unsupported by a healthcare provider for contraception (AOR 2.2); and not feeling at risk of unintended pregnancy (AOR 2.7). While ≥70% of participants recognized most contraceptive methods, awareness of some methods was lacking. Nearly all respondents (91%) felt at least one modern method was unsafe. Nearly half of all females (45%) reported their last pregnancy was unintended, and 63% of females and 58% of males felt at risk for future unintended pregnancy. Women were more likely to experience unintended pregnancy if they had ever given birth (AOR 6.7), their sexual debut was 8–14 years versus 20–24 years (AOR 3.4), or they had 3–4 lifetime sexual partners versus 1–2 (AOR 2.4). Targeted interventions are needed to improve understanding of the safety of modern contraceptive methods, increase awareness of long-acting methods, and consequently increase modern contraceptive access and use.
- 1 December 2017
- Published by Elsevier in Contraception
- Vol. 96 (6) , 401-410
Mixed-methods investigation of women’s experiences with second-trimester abortion care in the Midwest and Northeast United States
- 1 December 2017
- Published by Elsevier in Contraception
- Vol. 96 (6) , 401-410
Mixed-methods investigation of women’s experiences with second-trimester abortion care in the Midwest and Northeast United States
- 1 October 2017
- Published by Elsevier in Contraception
- Vol. 96 (4) , 273
Nationally representative survey of women’s experiences with early pregnancy loss in the United States
- 1 October 2017
- Published by Elsevier in Contraception
- Vol. 96 (4) , 273
Nationally representative survey of women’s experiences with early pregnancy loss in the United States